Skip to content

Preventive effect of maxijesic on rebound pain

Effect of preemptive acetaminophen ibuprofen combination (Maxijesic) administration on relieving rebound pain after upper extremity surgery using supraclavicular block technique: A randomized study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0009479
Enrollment
78
Registered
2024-05-29
Start date
2024-07-23
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : This study is a double-blind study and will be conducted on patients undergoing hand and wrist surgery under supraclavicular block anesthesia who agree to participate in the study but do not me

Sponsors

Samsung Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: - Adults between 19 and 70 years of age - Patients undergoing bone surgery of the hand or wrist with supraclavicular block - American Society of Anesthesiologists Physical Status I, II, III

Exclusion criteria

Exclusion criteria: - Pregnant, lactating women - Patients with serious coagulopathy (INR 1.5 or higher on the last blood coagulation test before surgery) - Patients with unstable coronary artery disease, congestive heart failure, arrhythmia, and myocarditis - Patients with cerebrovascular disease - Patients with systemic infection or current infection in the area where supraclavicular block surgery will be performed (above the clavicle) - Patients who did not understand this study and expressed their intention not to participate in the study - Patients allergic to local anesthetics - Patients contraindicated in the test drug (Maxijesic Injection) ? Patients with a history of hypersensitivity to study drug or its components ? Patients with active alcoholism ? Patients with gastrointestinal ulcers, gastrointestinal bleeding, or patients with a history of gastrointestinal ulcers or gastrointestinal bleeding ? Patients with severe blood abnormalities ? Patients with severe liver and kidney disorders ? Patients with severe cardiac dysfunction ? Patients with severe hypertension ? Patients with bronchial asthma or a history of it ? Patients who have or have a history of hypersensitivity, such as an allergic reaction, to aspirin or other non-steroidal anti-inflammatory drugs. ? Patients experiencing pain before and after coronary artery bypass surgery ? Pregnant women ? Patients taking the following drugs: barbiturates, tricyclic antidepressants ? Patients receiving high-dose methotrexate for anticancer therapy - Others: autoimmune disease, history of drug hypersensitivity reaction, food allergy, chronic hives - Patients with a serious psychiatric history that may affect patient evaluation - Patients who failed supraclavicular block surgery

Design outcomes

Primary

MeasureTime frame
Rebound pain score

Secondary

MeasureTime frame
pain scores;Worst pain ;The time of first analgesic request;opioid consumption;Patient satisfaction: analgesia ,fist nigh sleep;Adverse event: nausea and vomiting ,dizziness, respiratory depression, block related complication

Countries

Korea, Republic of

Contacts

Public ContactYu Jeong Bang

Samsung Medical Center

gagreflex.bang@gmail.com+82-2-3410-1000

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026